Literature DB >> 1569650

The value of adrenal autotransplantation with attached blood vessels for the treatment of Cushing's disease: a preliminary report.

Y M Xu1, Z D Chen, Y Qiao, N T Jin.   

Abstract

We treated 5 patients with Cushing's disease by total adrenalectomy and left adrenal autotransplantation with attached blood vessels. An end-to-end vascular anastomosis was made between the adrenal central vein and the inferior epigastric artery, and the saphenous vein and adrenal middle artery were anastomosed by intussuscepting the artery into the vein in 4 patients. Steroid replacement was withdrawn 7 to 90 days after bilateral total adrenalectomy. The patients were followed for 1 to 4 years. Repeated measurement of plasma cortisol, 24-hour urinary 17-hydroxycorticosteroid and 17-ketosteroid levels in all cases was normal. As soon as the adrenal central vein and inferior epigastric artery were anastomosed part of the adrenal gland was then excised. Oozing of blood from the cut surface was retained and the adrenal gland was then embedded into the inguinal muscle in 1 patient. Small doses of steroid replacement (12.5 mg. cortisone per day) were still necessary 1 year postoperatively. The result thus indicates that this procedure is feasible and valuable for the treatment of patients with Cushing's disease and no evidence of pituitary adenoma on magnetic resonance imaging or computerized tomography.

Entities:  

Mesh:

Year:  1992        PMID: 1569650     DOI: 10.1016/s0022-5347(17)37518-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Successful autotransplantation of an adrenal gland using a new method of omental wrapping: report of a case.

Authors:  A Miyauchi; M Kihara; K Matsusaka; A Nishitani; Y Nishiyama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Role of bilateral adrenalectomy in Cushing's disease.

Authors:  G Favia; M Boscaro; F Lumachi; D F D'Amico
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.